BioSpace News Archive

ADC Therapeutics SA announced that the first patients have been dosed in a 100-patient pivotal Phase 2 clinical trial evaluating the efficacy and safety of ADCT-301 in patients with relapsed or refractory Hodgkin lymphoma The trial is intended to support the submission of a Biologics License Application to the U.S. Food and Drug Administration.

BC Platforms, a world leader in genomic data management and analytics, today announced that it has formed a collaboration with Blueprint Genetics, a leader in the field of clinical genetic testing, to develop new data driven services for hospitals and the life sciences industry.

Shimadzu Scientific Instruments, in partnership with the Enabling Technologies Consortium™, announces the release of the Nexera Preparative Supercritical Fluid Chromatography System.

Cytel Inc. has announced that the Complex Innovative Trial Design Symposium and East® Training will take place November 6–7 at Alexion’s headquarters in Boston, Massachusetts.

Not-for-profit organization i2 Learning administered professional development workshops in Attleboro, Everett, Peabody, Methuen and Westfield, made possible in part by $50,000 in MLSC funding

Lilly picked up pegilodecakin, an immunotherapy that stimulates the body’s immune system and expands tumor-attacking T-cells, when it acquired ARMO BioSciences in June 2018 for $1.6 billion.

Netherlands-based Pharming Group NV has denied any involvement in a potential theft of intellectual property belonging to CSL Behring from Joseph Chiao, who recently joined Pharming as medical director.

ArsenalBio will focus on integrating various technologies, including CRISPR, synthetic biology, and machine learning to discover and develop immunotherapies, initially for oncology.

No matter where in the process you are, here are the questions you should be asking your interviewer.

Pharma, biotech and medtech companies strengthen their executive ranks and boards with this week’s Movers & Shakers.